Nosocomial bloodstream infections in United States hospitals: a three-year analysis.

Nosocomial bloodstream infections are important causes of morbidity and mortality. In this study, concurrent surveillance for nosocomial bloodstream infections at 49 hospitals over a 3-year period detected >10,000 infections. Gram-positive organisms accounted for 64% of cases, gram-negative organisms accounted for 27%, and 8% were caused by fungi. The most common organisms were coagulase-negative staphylococci (32%), Staphylococcus aureus (16%), and enterococci (11%). Enterobacter, Serratia, coagulase-negative staphylococci, and Candida were more likely to cause infections in patients in critical care units. In patients with neutropenia, viridans streptococci were significantly more common. Coagulase-negative staphylococci were the most common pathogens on all clinical services except obstetrics, where Escherichia coli was most common. Methicillin resistance was detected in 29% of S. aureus isolates and 80% of coagulase-negative staphylococci. Vancomycin resistance in enterococci was species-dependent--3% of Enterococcus faecalis strains and 50% of Enterococcus faecium isolates displayed resistance. These data may allow clinicians to better target empirical therapy for hospital-acquired cases of bacteremia.

[1]  C. Campbell,et al.  Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997. , 1997, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[2]  Didier Pittet,et al.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.

[3]  Nosocomial enterococci resistant to vancomycin--United States, 1989-1993. , 1993, MMWR. Morbidity and mortality weekly report.

[4]  R N Jones,et al.  National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. , 1998, Diagnostic microbiology and infectious disease.

[5]  T. W. Austin.  Prevention and Control of Nosocomial Infections. , 1987 .

[6]  R. Wenzel,et al.  The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. , 1993, JAMA.

[7]  Ronald N. Jones,et al.  Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group. , 1997, Diagnostic microbiology and infectious disease.

[8]  Centersfordiseasecontrolandpr.  Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin. , 1997, MMWR. Morbidity and mortality weekly report.

[9]  Y. Fukuchi,et al.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin , 1997, The Lancet.

[10]  A. Ranaweera,et al.  Antimicrobial resistance , 1999 .

[11]  R. Gaynes,et al.  Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. , 1994, The Journal of infectious diseases.

[12]  F. Tenover,et al.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. , 1997, The Journal of antimicrobial chemotherapy.

[13]  M. Osterholm,et al.  Impediments to public health surveillance in the 1990s: the lack of resources and the need for priorities. , 1996, Journal of public health management and practice : JPHMP.

[14]  Ronald N. Jones,et al.  Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). , 1997, Diagnostic microbiology and infectious disease.

[15]  Ronald N. Jones,et al.  National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. , 1998, Diagnostic microbiology and infectious disease.

[16]  D. Soll,et al.  Hospital Specificity, Region Specificity, and Fluconazole Resistance of Candida albicans Bloodstream Isolates , 1998, Journal of Clinical Microbiology.

[17]  R. Wenzel,et al.  Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. , 1997, Diagnostic microbiology and infectious disease.

[18]  M. Pfaller,et al.  Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program. , 1998, Diagnostic microbiology and infectious disease.

[19]  M. Pfaller,et al.  Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes. , 1997, Diagnostic microbiology and infectious disease.

[20]  R. Wenzel,et al.  Vancomycin-resistant Enterococcus raffinosus: molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance program. , 1997, Diagnostic microbiology and infectious disease.